Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
18
pubmed:dateCreated
2005-9-21
pubmed:abstractText
Sporadic colorectal cancers often arise from a region of cells characterized by a "field defect" that has not been well defined molecularly. DNA methylation has been proposed as a candidate mediator of this field defect. The DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) is frequently methylated in colorectal cancer. We hypothesized that MGMT methylation could be one of the mediators of field cancerization in the colon mucosa.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1460-2105
pubmed:author
pubmed:issnType
Electronic
pubmed:day
21
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1330-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:16174854-Cell Line, Tumor, pubmed-meshheading:16174854-Colorectal Neoplasms, pubmed-meshheading:16174854-DNA Methylation, pubmed-meshheading:16174854-Epigenesis, Genetic, pubmed-meshheading:16174854-Gene Silencing, pubmed-meshheading:16174854-Humans, pubmed-meshheading:16174854-Intestinal Mucosa, pubmed-meshheading:16174854-Mutation, pubmed-meshheading:16174854-O(6)-Methylguanine-DNA Methyltransferase, pubmed-meshheading:16174854-Polymerase Chain Reaction, pubmed-meshheading:16174854-Promoter Regions, Genetic, pubmed-meshheading:16174854-Proto-Oncogene Proteins, pubmed-meshheading:16174854-Risk Factors, pubmed-meshheading:16174854-Sensitivity and Specificity, pubmed-meshheading:16174854-Sequence Analysis, DNA, pubmed-meshheading:16174854-Sulfites, pubmed-meshheading:16174854-Tumor Markers, Biological, pubmed-meshheading:16174854-Tumor Suppressor Protein p53, pubmed-meshheading:16174854-ras Proteins
pubmed:year
2005
pubmed:articleTitle
MGMT promoter methylation and field defect in sporadic colorectal cancer.
pubmed:affiliation
Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, N.I.H., Extramural